EIF2AK1
Basic information
Region (hg38): 7:6022247-6059175
Links
Phenotypes
GenCC
Source:
- leukoencephalopathy, motor delay, spasticity, and dysarthria syndrome (Limited), mode of inheritance: AD
- leukoencephalopathy, motor delay, spasticity, and dysarthria syndrome (Limited), mode of inheritance: Unknown
- leukoencephalopathy, motor delay, spasticity, and dysarthria syndrome (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Leukoencephalopathy, motor delay, spasticity, and dysarthria syndrome | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 32197074 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (147 variants)
- not_specified (84 variants)
- Leukoencephalopathy,_motor_delay,_spasticity,_and_dysarthria_syndrome (7 variants)
- EIF2AK1-related_disorder (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the EIF2AK1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000014413.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 27 | 32 | ||||
| missense | 123 | 134 | ||||
| nonsense | 4 | |||||
| start loss | 1 | 1 | ||||
| frameshift | 1 | |||||
| splice donor/acceptor (+/-2bp) | 2 | |||||
| Total | 0 | 0 | 133 | 34 | 7 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| EIF2AK1 | protein_coding | protein_coding | ENST00000199389 | 15 | 36981 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 7.01e-7 | 0.999 | 125700 | 0 | 48 | 125748 | 0.000191 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.434 | 312 | 334 | 0.933 | 0.0000181 | 4077 |
| Missense in Polyphen | 67 | 97.993 | 0.68372 | 1207 | ||
| Synonymous | -0.693 | 143 | 133 | 1.08 | 0.00000796 | 1205 |
| Loss of Function | 2.89 | 16 | 34.2 | 0.468 | 0.00000172 | 414 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000653 | 0.000653 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000277 | 0.000272 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.000186 | 0.000185 |
| Middle Eastern | 0.000277 | 0.000272 |
| South Asian | 0.0000328 | 0.0000327 |
| Other | 0.000497 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Inhibits protein synthesis at the translation initiation level, in response to various stress conditions, including oxidative stress, heme deficiency, osmotic shock and heat shock. Exerts its function through the phosphorylation of EIF2S1 at 'Ser- 48' and 'Ser-51', thus preventing its recycling. Binds hemin forming a 1:1 complex through a cysteine thiolate and histidine nitrogenous coordination. This binding occurs with moderate affinity, allowing it to sense the heme concentration within the cell. Thanks to this unique heme-sensing capacity, plays a crucial role to shut off protein synthesis during acute heme-deficient conditions. In red blood cells (RBCs), controls hemoglobin synthesis ensuring a coordinated regulation of the synthesis of its heme and globin moieties. Thus plays an essential protective role for RBC survival in anemias of iron deficiency. Similarly, in hepatocytes, involved in heme-mediated translational control of CYP2B and CYP3A and possibly other hepatic P450 cytochromes. May also contain ER stress during acute heme-deficient conditions (By similarity). {ECO:0000250}.;
- Pathway
- Influenza A - Homo sapiens (human);Protein processing in endoplasmic reticulum - Homo sapiens (human);Hepatitis C - Homo sapiens (human);Measles - Homo sapiens (human);Epstein-Barr virus infection - Homo sapiens (human);Herpes simplex infection - Homo sapiens (human);Translation Factors;regulation of eif2
(Consensus)
Recessive Scores
- pRec
- 0.294
Intolerance Scores
- loftool
- 0.796
- rvis_EVS
- 0.36
- rvis_percentile_EVS
- 74.63
Haploinsufficiency Scores
- pHI
- 0.136
- hipred
- Y
- hipred_score
- 0.595
- ghis
- 0.477
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.371
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Eif2ak1
- Phenotype
- homeostasis/metabolism phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype;
Gene ontology
- Biological process
- acute inflammatory response;phagocytosis;negative regulation of cell population proliferation;regulation of translational initiation by eIF2 alpha phosphorylation;regulation of eIF2 alpha phosphorylation by heme;macrophage differentiation;negative regulation of translational initiation by iron;protoporphyrinogen IX metabolic process;protein autophosphorylation;negative regulation of hemoglobin biosynthetic process;iron ion homeostasis;response to iron ion starvation
- Cellular component
- cytoplasm
- Molecular function
- protein kinase activity;eukaryotic translation initiation factor 2alpha kinase activity;ATP binding;heme binding;protein homodimerization activity